Thus, in general, the stool microbiota of MS patients does resemble earlier findings of a more pro-inflammatory composition containing higher proportions of gram-negative bacteria possibly triggering inflammation via production of lipopolysaccharide that activates TLR4 signaling14,16. Here, TLR4 is linked to myeloid sarcoma.